Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
about
Pulmonary Hypertension and Indicators of Right Ventricular FunctionHIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatmentPathobiology of pulmonary arterial hypertension and right ventricular failureDNA Damage and Pulmonary HypertensionInflammatory cytokines in pulmonary hypertensionBiomarkers for pediatric pulmonary arterial hypertension - a call to collaborateNovel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)STAT5a/b contribute to sex bias in vascular disease: A neuroendocrine perspectiveLack of bcr and abr promotes hypoxia-induced pulmonary hypertension in miceTherapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial HypertensionWorld Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.IL-32 promotes angiogenesis.Kidney dysfunction in patients with pulmonary arterial hypertensionSevere pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patientsErythropoietin upregulation in pulmonary arterial hypertensionInflammation and immunity in the pathogenesis of pulmonary arterial hypertensionAdventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertensionComplement C3 deficiency attenuates chronic hypoxia-induced pulmonary hypertension in mice.Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia.Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease.Neuroinflammation in pulmonary hypertension: concept, facts, and relevance.Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 geneAdenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodelingPulmonary hypertension in POEMS syndrome: resolution following radiotherapy.Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertensionMarkers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension.Role of prostacyclin in pulmonary hypertension.Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertensionInterleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension.High-mobility group box-1 induces vascular remodelling processes via c-Jun activationEosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension.Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension.Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.Variations in levels of IL-6 and TNF-α in type 2 diabetes mellitus between rural and urban Ashanti Region of Ghana.Obesity and pulmonary arterial hypertension: Is adiponectin the molecular link between these conditions?
P2860
Q26744781-6C445989-C082-4A86-B54A-E1DD752081F9Q26777241-926EE727-125C-4824-9D75-2A0EA4DD8511Q26821779-94331A66-9FF3-4C36-9B78-A144A585563EQ27005594-E803D8FC-22AA-46A9-AA79-44572D830010Q27007510-C3CC5427-D28E-40A1-9C0B-928E2B9BC228Q27026465-F86C4E04-6E92-4273-AE5B-B9B17DACB38FQ28078976-5F02E801-DEFA-4A41-8235-AD75E3867D0FQ28081115-7E4D8E79-3966-4F63-AD83-88663E60D484Q28512646-BBE38692-7FF1-489B-8D78-26950CAD9303Q28553086-DDA6C917-77E7-4E9B-922D-28EB42A0EBAFQ30248878-A3AFAAB5-9C41-4383-9A62-9CC99514F370Q30544892-9871545C-B77D-4512-803D-5BEC4520DEA5Q33555523-1B48B73D-8BC9-4ABA-A7DF-EF0930B4C90AQ33738621-C59FD46E-EFA8-4405-9A85-5C560C526BA6Q33764990-30525C48-21E1-4FB6-9822-24F16EBCF92AQ33788533-964AA661-829B-4DD8-9A2E-86AB9F1EC7ADQ33805982-1E16D850-931E-4ECE-AA2E-7559C31D4E26Q33898213-2D9E6A16-CE30-4AFC-8BBA-FC601374329CQ33909537-E580E3BD-D9D4-4D60-9DC8-1B6665F9F01DQ33965859-0F29A7B2-54CF-45CD-A253-7F9A91BF9CE7Q34110164-AB0BF24C-8514-4699-9165-A61B8AB3E641Q34182389-002CF861-04CD-432D-9D80-9EBCC04FC47AQ34196738-F2EBA79E-C0D6-4FC0-9F88-D1F653FC8716Q34205701-0E88C9AF-C321-4C07-B4D5-7242C9BC1D08Q34576173-605335E6-C0C8-4007-885F-D4DBA2AFB42EQ34683611-DABEED87-E270-4EDC-842F-2A6F9806BCDFQ34782645-10018F53-714F-431C-B7D4-1CDD5A8E3F04Q35014605-36EEA60E-7566-4B80-84B7-9AB954B0CBA4Q35053507-B9C7642F-A5B8-49EC-A684-DC617CEB7A7EQ35061559-ADA47353-13E4-4D33-A7EF-E4CA2B1D4066Q35165100-1C416F88-86E7-4CA0-AF88-5BEA9F70A967Q35175427-A4613EA0-0E66-4CCD-BA0D-36799A882F7AQ35565086-F1D3C74E-410E-4992-8712-5B263F9160F4Q35571972-982DBABA-D057-4B0D-851F-C3C62B0555F6Q35601475-34F12063-C505-44E8-B8EF-376B508EFE18Q35644609-3F1E385F-DEE7-4BD3-8285-269432DA8397Q35766646-23ED1754-8222-42F9-A56A-89F475A4E423Q35779717-6E6988E2-C6B0-4277-93DF-732353B573DCQ35782503-54BD9828-59B7-438A-87ED-B0B39A5078C9Q35896190-91E3F923-234D-465E-84D2-AD4D86781CA4
P2860
Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
description
im August 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 16 August 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2010
@uk
name
Elevated Levels of Inflammator ...... ulmonary Arterial Hypertension
@en
Elevated Levels of Inflammator ...... ulmonary Arterial Hypertension
@nl
type
label
Elevated Levels of Inflammator ...... ulmonary Arterial Hypertension
@en
Elevated Levels of Inflammator ...... ulmonary Arterial Hypertension
@nl
prefLabel
Elevated Levels of Inflammator ...... ulmonary Arterial Hypertension
@en
Elevated Levels of Inflammator ...... ulmonary Arterial Hypertension
@nl
P2093
P50
P1433
P1476
Elevated levels of inflammator ...... ulmonary arterial hypertension
@en
P2093
Alan M Holmes
Carmen M Treacy
Christoph Walker
David C Budd
Joanna Pepke-Zaba
Lucy Barker
Natalie J Doughty
Nicholas W Morrell
Paul Nicklin
Simon Jennings
P304
P356
10.1161/CIRCULATIONAHA.109.933762
P407
P577
2010-08-16T00:00:00Z